Related Experiment Video
Updated: Jun 3, 2026
08:46
Implementation of In Vitro Drug Resistance Assays: Maximizing the Potential for Uncovering Clinically Relevant Resistance Mechanisms
Published on: December 9, 2015
Dodging drug-resistant cancer with diamonds
Timothy J Merkel1, Joseph M DeSimone
1Department of Chemistry, University of North Carolina, Chapel Hill, NC 27599, USA.
Science Translational Medicine
|March 11, 2011
Summary
Nanodiamond carriers effectively delivered chemotherapy, overcoming drug resistance in liver cancer. This approach enhanced treatment efficacy and reduced toxicity in both cell cultures and mouse models.
Area of Science:
- Biomedical Engineering
- Nanotechnology
- Oncology
Background:
- Chemoresistance, particularly drug-efflux mediated by adenosine 5'-triphosphate (ATP)-binding cassette (ABC) transporters, poses a significant challenge in treating metastatic cancers.
- Developing novel drug delivery systems is crucial for overcoming multidrug resistance and improving therapeutic outcomes.
Purpose of the Study:
- To investigate the potential of nanodiamond carriers for delivering chemotherapeutics to overcome drug-efflux based chemoresistance in cancer.
- To evaluate the efficacy and toxicity of nanodiamond-mediated doxorubicin delivery compared to free doxorubicin.
Main Methods:
- Utilized nanodiamond carriers (2-8 nanometers) for the delivery of doxorubicin (Dox).
- Assessed the effects of nanodiamond-mediated Dox delivery on liver cancer cells in vitro.
- Evaluated the therapeutic efficacy and toxicity of nanodiamond-mediated Dox delivery in vivo using mouse liver tumor models.
Main Results:
- Nanodiamond-mediated Dox delivery demonstrated prolonged therapeutic activity compared to free Dox.
- Increased apoptosis (programmed cell death) was observed with nanodiamond-mediated delivery.
- Reduced toxicity was noted when using nanodiamond carriers for Dox delivery.
Conclusions:
- Nanodiamond carriers show significant promise as a strategy to overcome ABC transporter-mediated chemoresistance.
- This nanodiamond-mediated drug delivery approach may offer a broadly applicable solution for enhancing chemotherapy efficacy in various cancers.
More Related Videos
08:59Looking for Driver Pathways of Acquired Resistance to Targeted Therapy: Drug Resistant Subclone Generation and Sensitivity Restoring by Gene Knock-down
Published on: December 11, 2017
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
Related Concept Videos
02:56Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:56Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:57Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
02:50Combination Therapies and Personalized Medicine
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
02:18Cancer
Cancers arise due to mutations in genes involved in the regulation of cell division, which leads to unrestricted cell proliferation. Modern science and medicine have made great strides in the understanding and treatment of cancer, including eradicating cancer in some patients. However, there is still no cure for cancer. This is largely due to the fact that cancer is a large group of many diseases.